Clinical and laboratory data in HD and healthy women.

Reference values: HOMA-IR, 2.1 T 0.7; Triglycerides, <150 mg/dl; HDL cholesterol, >50 mg/dl; hS C-reactive protein, <0.3 mg/dl; Estradiol, <44 pg/ml (post menopause without HT);
Oxidized LDL, <0.5 nmol/mg ApoPt.
BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance; RBCV1: red blood cell velocity before estradiol: RBCVmax1: peak red blood cell velocity before estradiol: RBCV1 increment: % of RBCVmax1 increase in relation to RBCV1; TRBCVmax1: time to reach peak red blood cell velocity before estradiol; RBCV2: red blood cell velocity after estradiol: RBCVmax2: peak red blood cell velocity after estradiol: RBCV2 increment: % of RBCVmax2 increase in relation to RBCV2: TRBCVmax2: time to reach peak red blood cell velocity after estradiol. Comparison between groups was performed by Mann Whitney test.

参考值：胰岛素抵抗稳态模型评估法（HOMA-IR）：2.1 T 0.7；甘油三酯（Triglycerides）：<150 mg/dl；高密度脂蛋白胆固醇（HDL cholesterol）：>50 mg/dl；高敏C反应蛋白（hS C-reactive protein）：<0.3 mg/dl；雌二醇（Estradiol）：<44 pg/ml（绝经后未接受激素治疗者）；氧化低密度脂蛋白（Oxidized LDL）：<0.5 nmol/mg ApoPt。
术语定义：体重指数（BMI，body mass index）；胰岛素抵抗稳态模型评估法（HOMA-IR，homeostasis model assessment of insulin resistance）；RBCV1：雌二醇给药前红细胞流速；RBCVmax1：雌二醇给药前红细胞峰值流速；RBCV1 increment：雌二醇给药前红细胞流速增幅占RBCVmax1的百分比；TRBCVmax1：雌二醇给药前达到红细胞峰值流速的时间；RBCV2：雌二醇给药后红细胞流速；RBCVmax2：雌二醇给药后红细胞峰值流速；RBCV2 increment：雌二醇给药后红细胞流速增幅占RBCVmax2的百分比；TRBCVmax2：雌二醇给药后达到红细胞峰值流速的时间。
组间比较采用曼-惠特尼U检验（Mann Whitney test）。